FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200574148> ?p ?o ?g. }

• W4200574148 endingPage "7643" @default.
• W4200574148 startingPage "7643" @default.
• W4200574148 abstract "Cannabinoids act as pleiotropic compounds exerting, among others, a broad-spectrum of neuroprotective effects. These effects have been investigated in the last years in different preclinical models of neurodegeneration, with the cannabinoid type-1 (CB1) and type-2 (CB2) receptors concentrating an important part of this research. However, the issue has also been extended to additional targets that are also active for cannabinoids, such as the orphan G-protein receptor 55 (GPR55). In the present study, we investigated the neuroprotective potential of VCE-006.1, a chromenopyrazole derivative with biased orthosteric and positive allosteric modulator activity at GPR55, in murine models of two neurodegenerative diseases. First, we proved that VCE-006.1 alone could induce ERK1/2 activation and calcium mobilization, as well as increase cAMP response but only in the presence of lysophosphatidyl inositol. Next, we investigated this compound administered chronically in two neurotoxin-based models of Parkinson's disease (PD), as well as in some cell-based models. VCE-006.1 was active in reversing the motor defects caused by 6-hydroxydopamine (6-OHDA) in the pole and the cylinder rearing tests, as well as the losses in tyrosine hydroxylase-containing neurons and the elevated glial reactivity detected in the substantia nigra. Similar cytoprotective effects were found in vitro in SH-SY5Y cells exposed to 6-OHDA. We also investigated VCE-006.1 in LPS-lesioned mice with similar beneficial effects, except against glial reactivity and associated inflammatory events, which remained unaltered, a fact confirmed in BV2 cells treated with LPS and VCE-006.1. We also analyzed GPR55 in these in vivo models with no changes in its gene expression, although GPR55 was down-regulated in BV2 cells treated with LPS, which may explain the lack of efficacy of VCE-006.1 in such an assay. Furthermore, we investigated VCE-006.1 in two genetic models of amyotrophic lateral sclerosis (ALS), mutant SOD1, or TDP-43 transgenic mice. Neither the neurological decline nor the deteriorated rotarod performance were prevented with this compound, and the same happened with the elevated microglial and astroglial reactivities, albeit modest spinal motor neuron preservation was achieved in both models. We also analyzed GPR55 in these in vivo models and found no changes in both TDP-43 transgenic and mSOD1 mice. Therefore, our findings support the view that targeting the GPR55 may afford neuroprotection in experimental PD, but not in ALS, thus stressing the specificities for the development of cannabinoid-based therapies in the different neurodegenerative disorders." @default.
• W4200574148 created "2021-12-31" @default.
• W4200574148 creator A5004342431 @default.
• W4200574148 creator A5008498660 @default.
• W4200574148 creator A5009140992 @default.
• W4200574148 creator A5014543463 @default.
• W4200574148 creator A5016002172 @default.
• W4200574148 creator A5018669039 @default.
• W4200574148 creator A5019389835 @default.
• W4200574148 creator A5036189795 @default.
• W4200574148 creator A5043016138 @default.
• W4200574148 creator A5045233330 @default.
• W4200574148 creator A5049331909 @default.
• W4200574148 creator A5081011378 @default.
• W4200574148 creator A5083930081 @default.
• W4200574148 creator A5091516968 @default.
• W4200574148 date "2021-12-16" @default.
• W4200574148 modified "2023-10-15" @default.
• W4200574148 title "Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis" @default.
• W4200574148 cites W1146102393 @default.
• W4200574148 cites W1512186305 @default.
• W4200574148 cites W1536828728 @default.
• W4200574148 cites W1602202713 @default.
• W4200574148 cites W1928757774 @default.
• W4200574148 cites W1940894649 @default.
• W4200574148 cites W1943627496 @default.
• W4200574148 cites W1967493869 @default.
• W4200574148 cites W1977183929 @default.
• W4200574148 cites W1980388563 @default.
• W4200574148 cites W1982478174 @default.
• W4200574148 cites W1983701850 @default.
• W4200574148 cites W1994033057 @default.
• W4200574148 cites W1998934835 @default.
• W4200574148 cites W2005019545 @default.
• W4200574148 cites W2005194978 @default.
• W4200574148 cites W2007143406 @default.
• W4200574148 cites W2018978047 @default.
• W4200574148 cites W2019444314 @default.
• W4200574148 cites W2027927927 @default.
• W4200574148 cites W2029003083 @default.
• W4200574148 cites W2041353400 @default.
• W4200574148 cites W2044784707 @default.
• W4200574148 cites W2048347153 @default.
• W4200574148 cites W2049867157 @default.
• W4200574148 cites W2062758588 @default.
• W4200574148 cites W2063285691 @default.
• W4200574148 cites W2066139135 @default.
• W4200574148 cites W2077467150 @default.
• W4200574148 cites W2079856528 @default.
• W4200574148 cites W2082433795 @default.
• W4200574148 cites W2106182910 @default.
• W4200574148 cites W2114447482 @default.
• W4200574148 cites W2123184750 @default.
• W4200574148 cites W2136798984 @default.
• W4200574148 cites W2146663965 @default.
• W4200574148 cites W2171756202 @default.
• W4200574148 cites W2172278003 @default.
• W4200574148 cites W2210409717 @default.
• W4200574148 cites W2331963514 @default.
• W4200574148 cites W2396236411 @default.
• W4200574148 cites W2415246453 @default.
• W4200574148 cites W2431558107 @default.
• W4200574148 cites W2442238093 @default.
• W4200574148 cites W2492716730 @default.
• W4200574148 cites W2501047946 @default.
• W4200574148 cites W2502465441 @default.
• W4200574148 cites W2596378090 @default.
• W4200574148 cites W2604423022 @default.
• W4200574148 cites W2726332214 @default.
• W4200574148 cites W2745292704 @default.
• W4200574148 cites W2747266557 @default.
• W4200574148 cites W2766767705 @default.
• W4200574148 cites W2767738407 @default.
• W4200574148 cites W2784023895 @default.
• W4200574148 cites W2791482559 @default.
• W4200574148 cites W2793446839 @default.
• W4200574148 cites W2806498105 @default.
• W4200574148 cites W2807482700 @default.
• W4200574148 cites W2887287732 @default.
• W4200574148 cites W2887594646 @default.
• W4200574148 cites W2901024921 @default.
• W4200574148 cites W2906876155 @default.
• W4200574148 cites W2907644153 @default.
• W4200574148 cites W2914319179 @default.
• W4200574148 cites W2921816807 @default.
• W4200574148 cites W2981887684 @default.
• W4200574148 cites W3007845466 @default.
• W4200574148 cites W3033039299 @default.
• W4200574148 cites W3044090000 @default.
• W4200574148 cites W3088978368 @default.
• W4200574148 cites W3095739249 @default.
• W4200574148 cites W3112039081 @default.
• W4200574148 cites W3124802417 @default.
• W4200574148 cites W3133835086 @default.
• W4200574148 cites W3161228501 @default.
• W4200574148 cites W3163394301 @default.
• W4200574148 cites W3164693358 @default.
• W4200574148 cites W3192578143 @default.

• next